Harvard Review Articles in Pharmacoepidemiology


Please mail comments on any article to ddil@episun1.harvard.edu. A digest of readers' comments will be appended to each article.

Updated June 12, 1999



Routine Varicella Immunization for Children: Basis of the Program Implementation in the US, by Ekundayo Ajayi-Obe and Johannes G. Liese (6/12/99)

Drugs Removed from the Market or Receiving Black Box Warnings in the United States 1997-1997 and Matched Drugs with Uneventful Safety Histories: Narrative Description, by Jennifer I. Kuesters, Linda J. Lawrie, Rebecca S. Wells, and Alexander M. Walker (6/8/99)

Chelation Therapy for Childhood Lead Poisoning: Does Excretion Equal Efficacy ?, by Adrienne S. Ettinger (4/23/99)

Selective Serotonin Reuptake Inhibitors And Sexual Dysfunction: A Historical Review Of The Development Of Evidence For An Adverse Effect, by Anita K. Wagner (4/14/99)

Nonsteroidal anti-inflammatory drugs and blood pressure, by Chen-Chang Yang (4/14/99)

Should Phen-Pro Replace Phen-fen?, by Candice Silversides and Sara Cherkerzian (10/21/98)

KETOROLAC AND GASTROINTESTINAL TOXICITY: A perspective from 1998, by Francisco J. De Abajo (6/9/98)

Alexander M. Walker reviews the history of Aminorex (12/2/97)

Pertussis Vaccination and Serious Central Nervous System Disorders: Early Case Series Evidence and Public Reaction, by Margaret Ann Goetz. (8/7/97)

Drug-Induced Parkinsonism: Are Cinnarizine and Flunarizine Implicated?, by Guilherme L. Werneck. (7/7/97)

The Influenza A/New Jersey (Swine Flu) Vaccine and Guillain-Barré Syndrome: the arguments for a causal association, by Elissa A. Laitin and Elise M. Pelletier. (6/20/97)

Serevent and increased morbidity and mortality from asthma: a historical review of the evidence, by Steve Duff. (6/18/97)

The relationship between benzodiazepines and hip fracture in the elderly, by Eileen Ming. (6/18/97)

Adverse effects of botanical and non-botanical ephedrine products, by June Weintraub. (6/18/97)

The relationship between stimulants and tic disorders in children treated for Attention Deficit Hyperactivity Disorder, by Eric Mick. (6/18/97)

Vera Mastey provides a historical review of Torsades de Pointes in Patients Receiving Terfenadine or Astemizole. (8/23/95)

James Hegarty describes the evolution of a controversy over whether Prozac could cause violence in Suicidal and violent behavior associated with the use of fluoxetine. (6/22/95)

Alexander M. Walker discusses when data must be regarded as "personally identified," in Generic Data. (4/18/95)

Philip S. Wang reviews the carcinogenicity of antidepressants in The Epidemiology of Depression and Cancer: Do Antidepressant Medications Play a Role? (4/18/95)



 

Return to the DDIL Homepage

This document has been provided through the Drugs and Devices Information Line, http://www.hsph.harvard.edu/Organizations/DDIL/ddil.html

If you have questions or comments about the DDIL, please write to: ddil@episun1.harvard.edu